Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Hims & Hers Health Inc
Recent news which mentions Hims & Hers Health Inc
Hims & Hers stock falls 10% on revenue miss
August 04, 2025
Tags
Earnings
Novo Nordisk A/S
Breaking News: Business
From
CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
July 23, 2025
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Doximity Inc
From
CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
July 09, 2025
Tags
Pharmaceuticals
Health care industry
Companies
From
CNBC.com News
5 things to know before the stock market opens Tuesday
June 24, 2025
Tags
Investing
Hims & Hers Health Inc
5 Things to Know
From
CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
June 23, 2025
Tags
Pharmaceuticals
Companies
Health care industry
From
CNBC.com News
Hims & Hers to acquire European telehealth platform in global expansion
June 03, 2025
Tags
Health care industry
Health & Science
Business
From
CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
May 06, 2025
Tags
Make It
Novo Nordisk A/S
Hims & Hers Health Inc
From
CNBC.com News
Hims & Hers gives weak outlook but says more collaborations are coming
May 05, 2025
Tags
Internet
Media
Health care industry
From
CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
May 05, 2025
Tags
Hims & Hers Health Inc
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
April 29, 2025
Tags
Business News
Companies
Health care industry
From
CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
April 25, 2025
Tags
Social issues
Companies
Health care industry
From
CNBC.com News
Hims & Hers shares rise as company adds new weight-loss medications to platform
April 01, 2025
Tags
Enterprise
Breaking News: Technology
Technology
From
CNBC.com News
Zepbound copycats remain online despite FDA ban
March 21, 2025
Tags
Hims & Hers Health Inc
Health & Science
US: News
From
CNBC.com News
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
February 25, 2025
Tags
Technology
Breaking News: Technology
Mobile
From
CNBC.com News
5 things to know before the stock market opens Tuesday
February 25, 2025
Tags
Markets
Home Depot Inc
NVIDIA Corp
From
CNBC.com News
Hims & Hers shares tumble as margin miss adds to concerns about GLP-1 business
February 24, 2025
Tags
Internet
Health care industry
Enterprise
From
CNBC.com News
Cramer's week ahead: Earnings from Nvidia, Dell and Home Depot
February 21, 2025
Tags
Dell Technologies Inc
Workday Inc
Investing
From
CNBC.com News
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
February 21, 2025
Tags
Health & Science
Breaking News: Business
Hims & Hers Health Inc
From
CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
February 21, 2025
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Health & Science
Novo Nordisk A/S
Hims & Hers Health Inc
From
CNBC.com News
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
February 19, 2025
Tags
Health care industry
Business
Business News
From
CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
February 07, 2025
Tags
Mobile
Health care industry
Internet
From
CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
February 04, 2025
Tags
Investment Strategy
Mad Money
Markets
From
CNBC.com News
Hims & Hers donates $1 million to Trump's inauguration fund
January 07, 2025
Tags
Apple Inc
Amazon/com Inc
Health & Science
From
CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
December 24, 2024
Tags
US: News
Health & Science
Hims & Hers Health Inc
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
Obesity
Meta Platforms Inc
Health care industry
From
CNBC.com News
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%
November 14, 2024
Tags
Breaking News: Technology
Technology
Health care industry
From
CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
October 08, 2024
Tags
Pfizer Inc
Health care industry
Social issues
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
Wells Fargo & Co
Stock markets
Constellation Energy Corp
From
CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
September 12, 2024
Tags
Hims & Hers Health Inc
Health & Science
Enterprise
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today
